|
Report Date : |
29.01.2013 |
IDENTIFICATION DETAILS
|
Name : |
GENOMMA LABORATORIES ARGENTINA S.A. |
|
|
|
|
Registered Office : |
Av. Gral Las Heras 1947, Piso 6º, CABA. |
|
|
|
|
Country : |
Argentina |
|
|
|
|
Date of Incorporation : |
25.04.2007 |
|
|
|
|
Legal Form : |
Public Limited Company |
|
|
|
|
Line of Business : |
Medicinal Product Development for Use Human |
|
|
|
|
No. of Employees : |
68 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit: |
USD $ 185.000 |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30th, 2012
|
Country Name |
Previous Rating (31.03.2012) |
Current Rating (30.06.2012) |
|
Argentina |
B1 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
argentina - ECONOMIC OVERVIEW
Argentina benefits from rich natural resources, a highly literate population, an export-oriented agricultural sector, and a diversified industrial base. Although one of the world's wealthiest countries 100 years ago, Argentina suffered during most of the 20th century from recurring economic crises, persistent fiscal and current account deficits, high inflation, mounting external debt, and capital flight. A severe depression, growing public and external indebtedness, and a bank run culminated in 2001 in the most serious economic, social, and political crisis in the country's turbulent history. Interim President Adolfo RODRIGUEZ SAA declared a default - the largest in history - on the government's foreign debt in December of that year, and abruptly resigned only a few days after taking office. His successor, Eduardo DUHALDE, announced an end to the peso's decade-long 1-to-1 peg to the US dollar in early 2002. The economy bottomed out that year, with real GDP 18% smaller than in 1998 and almost 60% of Argentines under the poverty line. Real GDP rebounded to grow by an average 8.5% annually over the subsequent six years, taking advantage of previously idled industrial capacity and labor, an audacious debt restructuring and reduced debt burden, excellent international financial conditions, and expansionary monetary and fiscal policies. Inflation also increased, however, during the administration of President Nestor KIRCHNER, which responded with price restraints on businesses, as well as export taxes and restraints, and beginning in early 2007, with understating inflation data. Cristina FERNANDEZ DE KIRCHNER succeeded her husband as President in late 2007, and the rapid economic growth of previous years began to slow sharply the following year as government policies held back exports and the world economy fell into recession. The economy has rebounded strongly from the 2009 recession, but the government's continued reliance on expansionary fiscal and monetary policies risks exacerbating already high inflation.
|
Source : CIA |
GENOMMA
LABORATORIES ARGENTINA S.A.
C.U.I.T. 30-71012195-4
INCORPORATED IN 2007. BEGINNER OF ACTIVITIES. IT DOESN'T SUPPLY
FINANCIAL INFORMATION. STABLE PERSPECTIVES. IT FULFILLS ITS COMMITMENTS. FIT
FOR CREDITS WITH ADDITIONAL SECURITIES.
MEDICINAL PRODUCT DEVELOPMENT FOR USE HUMAN.
LEGAL FORM:
PUBLIC LIMITED
COMPANY
CREATED: 25/04/2007
REGISTERED RPC: 15/05/2007
DURATION: 99 YEARS
END OF FISCAL YEAR: 31/12
AFIP: Nº 56, AV.DEL LIBERTADOR 1436, VTE LOPEZ, PCIA DE BS.AS.
Mr. FEDERICO LAPORTE. (Administracion)
Legal address: Av. Gral Las Heras 1947, Piso 6º, CABA.
Operative and Administrative address: Domingo de Acassuso 3780, Olivos, (1636)
Province of Bs.As., Republic of Argentina.
Phone/fax: 54-11 4801-3080
E-mail: flaporte@genommalab.com.ar
www.genommalab.com.ar
PRESIDENT
MAXIMO JUDA
ALTERNATE DIRECTOR ALEJANDRO
CIERO
Using signature: Paid by the President.
SOCIAL CAPITAL $ 185.000.-
MAXIMO
JUDA:
------------
argentino, single, born 11/10/1976, with DNI Nº 25.598.797.
While the holder is responsible for a wealth
of details on the matter, based on data contained in our power is being able to
quote it as an initiator of the activities being developed and which is located
in the address set forth in the heading.
The head is part of "GROUP GENOMMA", headed by Genomma Laboratories
S.A. de C.V. of Mexico, and multiple companies in the world.
No provided financial information to third parties.
CARTOCOR S.A.
SMURFITT KAPPA S.A.
Credits. u$s 40.000
Payments: 60/90 days.
Concept: Good.
The holder is engaged in the manufacture,
packaging, sale, marketing and distribution, import and export of medicinal and
pharmaceutical preparations, toiletries, cosmetics, nutritional additives,
dietary supplements, veterinary products, disinfectants, chemicals, etc.
Allocate a percentage of its budget for research and development and tried
productos.Analizado meet the needs of their consumers to improve their health
and wellbeing, by providing them with the latest research and technological
advances.
Since its founding Genomma Lab has a close connection with its distribution
channels, which is why today reaches several thousand outlets throughout the
country. Also exported to over 30 countries and have sales offices in Spain,
Argentina, Peru, China and India soon.
PRODUCTS:
---------
ASEPXIA
CICATRICURE
DALAY
GOICOECHEA
BENGUE
DIABET TX
GENOPRAZOL
GOICOTABS
POINTTS
SHOT D
SILKA MEDIC
NIKZON
X RAY
NEXT
BENGUE CAPS
BIO ELECTRO
UNIGASTROZOL
QG5
QUARA
TUKOL D
UNESIA
DERMO PRADA
QUIT
LOMECAN
FOREIGN TRADE:
--------------
In the last twelve months, it has made specific imports by u$s.8.311.053
according to the following detail:
MEXICO 8.049.053
ISRAEL 262.000
* 68 EMPLOYEES.
BANCO PATAGONIA
SUC. OLIVOS
STANDARD BANK
"
CREDIT RISK:
-------------
NOVEMBER 2012
BANCO PATAGONIA $ 60.483.800
SITUATION 1: NORMAL.
INSURANCE:
----------
LA CAJA S.A.
It doesn't register delinquencies, trials,
protests or other negative.
It fulfills correctly its commercial and bank commitments.
* NOT OBJECTIONS.
Keeping in mind its good backgrounds, the
company is feasible for credit treatment with appropriate guarantees.
* FIT FOR CREDITS
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.53.89 |
|
|
1 |
Rs.84.92 |
|
Euro |
1 |
Rs.72.51 |
INFORMATION DETAILS
|
Report Prepared
by : |
SDA |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.